Steven Fang

Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia.

Invitrocue Pte Ltd. provides products and services in the fields of in vitro drug metabolism and pharmacokinetics (DMPK), in vitro toxicology, and digital pathology utilizing cell-based models and image analytics. It also offers realms of drug testing and research and development of cosmeceuticals and medical devices solutions. The firm’s technology also provides cuepath platform, web-based platform, view share, manage, and analyze virtual slides and information. The company was founded by Steven Fang in 2012 and is headquartered in Singapore.